INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.350
-0.110 (-4.47%)
Sep 10, 2026, 12:21 PM EDT - Market open
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $65.22 million as of September 10, 2026. Its market cap has increased by 37.83% in one year.
Market Cap
65.22M
Enterprise Value
48.22M
1-Year Change
37.83%
Ranking
Category
Stock Price
$2.35
ChartMarket Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $65.22M, a decrease of -16.19%. That is a compound annual growth rate of -2.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 65.22M | 57.26% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 71.39M |
| Pliant Therapeutics | 71.21M |
| Nutriband | 70.50M |
| Champions Oncology | 69.61M |
| Spero Therapeutics | 68.13M |
| Eloxx Pharmaceuticals | 66.88M |
| XBiotech | 66.46M |
| LeonaBio | 66.33M |